Ref.: FD 00 520
EQUIP FT 10X1DS
Influenza + Tetanus
If you have already registered, log in to GirovetPro
Description
PHARMACEUTICAL FORM
Injectable suspension.
SPECIES
Horses.
Injectable suspension.
SPECIES
Horses.
Indications
For active immunization of healthy horses from 5 months of age against equine influenza virus types H7N7 and H3N8 (European or American strains, including isolates from Clado 1 and Clado 2 strains of the Florida sublineage) to reduce clinical signs and virus excretion after infection and against tetanus to prevent mortality.
- Duration of immunity: at least 15 months for equine influenza and 36 months for tetanus.
- Start of immunity: 2 weeks after the primary vaccination.
- Duration of immunity: at least 15 months for equine influenza and 36 months for tetanus.
- Start of immunity: 2 weeks after the primary vaccination.
Dose / Application / Administration
Routes of administration:
Shake repeatedly before use, and administer by deep intramuscular injection.
Dosage:
Dose: 2ml
The vaccine could be used on pregnant mares that have been vaccinated against equine influenza and tetanus before pregnancy.
Avoid stress when vaccinating mares in advanced stages of pregnancy.
Shake repeatedly before use, and administer by deep intramuscular injection.
Dosage:
Dose: 2ml
The vaccine could be used on pregnant mares that have been vaccinated against equine influenza and tetanus before pregnancy.
Avoid stress when vaccinating mares in advanced stages of pregnancy.
Composition
QUANTITATIVE AND QUALITATIVE COMPOSITION
Each dose (2ml) contains:
Active substance:
Inactivated strains of equine influenza virus: A/equine/Newmarket/77 (H7N7) ≥ 1.2 log10 IHA*
A/equine/Borlange/91 (H3N8) ≥ 2.1 log10 IHA* A/equine/Kentucky/98 ≥ 2.4 log10 IHA*
Toxoid of immunopurified tetanus (IPTT) ≥ 70 UI/ml
*Hemaglutination inhibitors antibodies title.
Adjuvants:
Saponin: 275-580µg
Phosphatidylcholine: 100-200µg
Cholesterol: 100-200µg
Aluminium phosphate: 4,5-5,5µg
Each dose (2ml) contains:
Active substance:
Inactivated strains of equine influenza virus: A/equine/Newmarket/77 (H7N7) ≥ 1.2 log10 IHA*
A/equine/Borlange/91 (H3N8) ≥ 2.1 log10 IHA* A/equine/Kentucky/98 ≥ 2.4 log10 IHA*
Toxoid of immunopurified tetanus (IPTT) ≥ 70 UI/ml
*Hemaglutination inhibitors antibodies title.
Adjuvants:
Saponin: 275-580µg
Phosphatidylcholine: 100-200µg
Cholesterol: 100-200µg
Aluminium phosphate: 4,5-5,5µg
Presentation
10 syringes of 2ml
Laboratory
ZOETIS
Leave us your comment